Cyto Pulse Sciences, Inc.
Cyto Pulse, the Karolinska Hospital/Institutet and SMI Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Evaluating a CEA-based Vaccine in Patients with Colorectal Cancer.
Published in Gene Therapy Weekly, November 19th, 2009
Cyto Pulse Sciences, a leading producer of electric field based, intradermal DNA Vaccine delivery systems, announced approval by the Swedish regulatory authorities to begin a Phase I/II study of DNA vaccination in patients with colorectal cancer. The trial will investigate the safety of a DNA vaccine delivered by the Derma Vax™ intradermal electroporation system. The vaccine, which encodes Carcinoembryonic Antigen (CEA), was developed jointly by the Swedish Institute for Infectious Disease Control (SMI)/Karolinska Institutet (KI) and Cyto Pulse.
Britta Wahren, M.D., Ph.D., Professor in Clinical Virology at KI/SMI and responsible for the CEA vaccine construct, says...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-11-19)
More Articles from Gene Therapy Weekly
- Alzheimer Disease
Research from University of Kuopio provides new data about Alzheimer disease - Anxiety Disorders
New anxiety disorders research reported from Stanford University - Cancer Vaccines
Study findings from R.C.F. Chan et al broaden understanding of cancer vaccines - Drug Delivery
Data on drug delivery detailed by researchers at Emory University - Enzyme Research
Studies from Kyoto Prefectural University have provided new information about enzyme research - Gene Therapy
Data on gene therapy published by J.R. Mendell and colleagues - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
